MEN1112

· Menarini Group

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MEN1112, covering 2024-08-12 to 2024-08-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of MEN1112 Intravenous Infusion in Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]